The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Novel Proteinaceous Infectious Particles Cause Scrapie
Abstract
After infection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats. Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity. Although the scrapie agent is irreversibly inactivated by alkali, five procedures with more specificity for modifying nucleic acids failed to cause inactivation. The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a molecular weight of 50,000 or less. Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term "prion" is proposed to denote a small pro teinaceous in fectious particle which is resistant to inactivation by most procedures that modify nucleic acids. Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Physical chemistry of macromolecules
(2007) · Choice Reviews Online · doi:10.5860/choice.45-2038 · Cited by 3,765
Central Dogma of Molecular Biology
CRICK, F. (1970) · Nature · doi:10.1038/227561a0 · Cited by 3,444
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Nature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161
Experimental Transmission of a Kuru-like Syndrome to Chimpanzees
GAJDUSEK, D. C., GIBBS, C. J., & ALPERS, M. (1966) · Nature · doi:10.1038/209794a0 · Cited by 837
FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES
LAWLEY, P., & BROOKES, P. (1963) · Biochemical Journal · doi:10.1042/bj0890127 · Cited by 797
Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee
Gibbs, C. J., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, E., Daniel, P. M., & Matthews, W. B. (1968) · Science · doi:10.1126/science.161.3839.388 · Cited by 779
Does the Agent of Scrapie Replicate without Nucleic Acid ?
ALPER, T., CRAMP, W. A., HAIG, D. A., & CLARKE, M. C. (1967) · Nature · doi:10.1038/214764a0 · Cited by 691
Unconventional Viruses and the Origin and Disappearance of Kuru
Gajdusek, D. C. (1977) · Science · doi:10.1126/science.142303 · Cited by 671
Research works printed but not linked: 88
- CAN MED ASS J 124: 1436 (1981).
- ADAMS, D.H., BIOCH SOC T 1: 1061 (1973). · doi:10.1042/bst0011061
- ADAMS, D.H., BRITISH MEDICAL JOURNAL 3: 1973 (1967).
- ADAMS, D.H., NATURE OF SCRAPIE AGENT - A REVIEW OF RECENT PROGRESS, PATHOLOGIE BIOLOGIE 18: 559 (1970).
- ALPERS, M, SLOW TRANSMISSIBLE D 1: 67 (1979).
- ANDREWS, P, METHODS OF BIOCHEMICAL ANALYSIS 18: 1 (1971).
- BARINGER, J.R., REGIONAL NEUROPATHOLOGY AND TITERS IN HAMSTER SCRAPIE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 40: 329 (1981).
- BASTIAN, F.O., SPIROPLASMA-LIKE INCLUSIONS IN CREUTZFELDT-JAKOB DISEASE, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 103: 665 (1979).
- BASTIAN, F.O., ADDITIONAL EVIDENCE OF SPIROPLASMA IN CREUTZFELDT-JAKOB DISEASE, LANCET 1: 660 (1981).
- BISHOP, J.M., ENEMIES WITHIN - THE GENESIS OF RETROVIRUS ONCOGENES, CELL 23: 5 (1981). · doi:10.1016/0092-8674(81)90263-4
- BORNSTEIN, P, SPECIFIC NONENZYMATIC CLEAVAGE OF BOVINE RIBONUCLEASE WITH HYDROXYLAMINE, JOURNAL OF BIOLOGICAL CHEMISTRY 245: 4854 (1970). · doi:10.1016/s0021-9258(18)62873-x
- Borrás, M.-T., Journal of General Virology 58: 263 (1982). · doi:10.1099/0022-1317-58-2-263
- BROWN, D.M., BASIC PRINCIPLES NUC 2: 1 (1974).
- BROWN, P, EFFECT OF DIFFERENT GRADIENT SOLUTIONS ON BUOYANT DENSITY OF SCRAPIE INFECTIVITY, PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 158: 513 (1978). · doi:10.3181/00379727-158-40236
- CHO, H.J., IS SCRAPIE AGENT A VIRUS, NATURE 262: 411 (1976). · doi:10.1038/262411a0
- CRAIG, R, THE THEORETICAL POSSIBILITY OF REVERSE TRANSLATION OF PROTEINS INTO GENES, JOURNAL OF THEORETICAL BIOLOGY 88: 757 (1981). · doi:10.1016/0022-5193(81)90250-2
- CUILLE, J, COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES 208: 1058 (1939).
- DARLINGTON, C.D., VIRUS DISEASES NERVO: 133 (1969).
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN BRAIN OF MICE, JOURNAL OF COMPARATIVE PATHOLOGY 79: 15 (1969). · doi:10.1016/0021-9975(69)90021-8
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN MOUSE SPLEEN, JOURNAL OF COMPARATIVE PATHOLOGY 79: 363 (1969). · doi:10.1016/0021-9975(69)90051-6
- DICKINSON, A.G., SLOW TRANSMISSIBLE D 1: 367 (1979).
- DICKINSON, A.G., SLOW VIRUS INFECTION: 3 (1977).
- DIENER, T.O., IS SCRAPIE AGENT A VIROID, NATURE-NEW BIOLOGY 235: 218 (1972).
- DIENER T.O. VIROIDS VIROID DISEA (1979). · doi:10.1016/b978-0-12-601950-6.50015-4
- FIELD, E.J., TRANSMISSION EXPERIMENTS WITH MULTIPLE SCLEROSIS - AN INTERIM REPORT, BRITISH MEDICAL JOURNAL 2: 564 (1966). · doi:10.1136/bmj.2.5513.564
- FIELD, E.J., DT Z NERVENHEILKUNDE 192: 265 (1967).
- FRANKLIN, R.M., INACTIVATION OF SOME ANIMAL VIRUSES BY HYDROXYLAMINE AND THE STRUCTURE OF RIBONUCLEIC ACID, NATURE 184: 343 (1959). · doi:10.1038/184343a0
- FREESE, E, HYDROXYLAMINE AS A MUTAGENIC AND INACTIVATING AGENT, JOURNAL OF MOLECULAR BIOLOGY 3: 133 (1961). · doi:10.1016/s0022-2836(61)80040-5
- GAJDUSEK, D.C., HUMAN DISEASES CAUSE: 231 (1978).
- GAJDUSEK, D.C., VIRUSES ENV: 79 (1978).
- GIANNONI, G, CRYSTALLIZATION OF DNA FROM DILUTE SOLUTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 62: 964 (1969).
- GIBBS, C.J., SLOW TRANSMISSIBLE D 2: 87 (1979).
- GORDON, W.S., VETERINARY RECORD 69: 1444 (1957).
- GORDON, W.S., VETERINARY RECORD 58: 516 (1946).
- GRAY, A, SPIROPLASMA AND CREUTZFELDT-JAKOB DISEASE, LANCET 2: 152 (1980).
- HAASE, A.T., INFECTIVITY OF VISNA VIRUS DNA, VIROLOGY 70: 65 (1976). · doi:10.1016/0042-6822(76)90236-1
- HADLOW, W.J., SCRAPIE AND KURU, LANCET 2: 289 (1959).
- HADLOW, W.J., VIROLOGIC AND NEUROHISTOLOGIC FINDINGS IN DAIRY GOATS AFFECTED WITH NATURAL SCRAPIE, VETERINARY PATHOLOGY 17: 187 (1980). · doi:10.1177/030098588001700207
- HAIG, D.A., SLOW LATENT TEMPERAT 2: 215 (1965).
- HOGAN, R.N., PROGRESSIVE RETINAL DEGENERATION IN SCRAPIE-INFECTED HAMSTERS - A LIGHT AND ELECTRON-MICROSCOPIC ANALYSIS, LABORATORY INVESTIGATION 44: 34 (1981).
- HUNTER, G.D., VIRAL AND NON-VIRAL PROPERTIES OF SCRAPIE AGENT, ANNALS OF CLINICAL RESEARCH 5: 262 (1973).
- HUNTER, G.D., ATTEMPTS TO RELEASE SCRAPIE AGENT FROM TISSUE DEBRIS, JOURNAL OF COMPARATIVE PATHOLOGY 77: 301 (1967). · doi:10.1016/0021-9975(67)90039-4
- HUNTER, G.D., SLOW TRANSMISSIBLE D 2: 365 (1979).
- KIMBERLIN, R.H., J GEN VIROL 1: 115 (1967).
- KIMBERLIN, R.H., EXPERIMENTAL SCRAPIE IN MOUSE - REVIEW OF AN IMPORTANT MODEL DISEASE, SCIENCE PROGRESS 63: 461 (1976).
- KIMBERLIN, R.H., SCRAPIE MOUSE: 1 (1976).
- KLEINKAUF, H, CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 91: 129 (1981).
- LATARJET, R, SLOW TRANSMISSIBLE D 2: 387 (1979).
- LEWIN, P, SCRAPIE - INFECTIVE PEPTIDE, LANCET 1: 748 (1972).
- MACKAY, JMK, DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE, NATURE 219: 182 (1968). · doi:10.1038/219182a0
- MALONE, T.G., MEMBRANE-FREE SCRAPIE ACTIVITY, JOURNAL OF VIROLOGY 25: 933 (1978). · doi:10.1128/jvi.25.3.933-935.1978
- MALONE, T.G., EVIDENCE FOR THE LOW-MOLECULAR WEIGHT NATURE OF SCRAPIE AGENT, NATURE 278: 575 (1979). · doi:10.1038/278575a0
- MANUELIDIS, E.E., SLOW TRANSMISSIBLE D 2: 147 (1979).
- MARSH, R.F., EVIDENCE FOR AN ESSENTIAL DNA COMPONENT IN SCRAPIE AGENT, NATURE 275: 146 (1978). · doi:10.1038/275146a0
- MCKINLEY, M.P., REVERSIBLE CHEMICAL MODIFICATION OF THE SCRAPIE AGENT, SCIENCE 214: 1259 (1981). · doi:10.1126/science.6795721
- MEANS, G.E., CHEM MODIFICATION PR: 1 (1971).
- MFADYEAN, J, J COMP PATHOL 31: 102 (1918). · doi:10.1016/s0368-1742(18)80015-7
- MILLSON, G.C., SLOW VIRUS DIS ANIMA: 243 (1976).
- MOULD, D.L., SCRAPIE IN MICE . STABILITY OF AGENT TO VARIOUS SUSPENDING MEDIA PH AND SOLVENT EXTRACTION, RESEARCH IN VETERINARY SCIENCE 6: 151 (1965). · doi:10.1016/s0034-5288(18)34749-0
- NARANG, H.K., RUTHENIUM RED AND LANTHANUM NITRATE A POSSIBLE TRACER AND NEGATIVE STAIN FOR SCRAPIE PARTICLES, ACTA NEUROPATHOLOGICA 29: 37 (1974). · doi:10.1007/bf00684389
- NOZTH, ACT, NATURE 191: 1242 (1961). · doi:10.1038/1911242a0
- PATTISON, I.H., FURTHER EXPERIMENTAL OBSERVATIONS ON SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 71: 350 (1961). · doi:10.1016/s0368-1742(61)80040-4
- PATTISON, I.H., DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE WITH SPECIAL REFERENCE TO POSSIBILITY OF ACCIDENTAL LABORATORY CONTAMINATION, RESEARCH IN VETERINARY SCIENCE 12: 30 (1971). · doi:10.1016/s0034-5288(18)34235-8
- PATTISON, I.H., VETERINARY RECORD 80: 1 (1967).
- PHILLIPS, J.H., PROGRESS NUCLEIC ACI 7: 349 (1967).
- PRUSINER, S.B., AGING BRAIN DEMENTIA: 205 (1980).
- PRUSINER, S.B., GEL-ELECTROPHORESIS AND GLASS PERMEATION CHROMATOGRAPHY OF THE HAMSTER SCRAPIE AGENT AFTER ENZYMATIC DIGESTION AND DETERGENT EXTRACTION, BIOCHEMISTRY 19: 4892 (1980). · doi:10.1021/bi00562a029
- PRUSINER, S.B., NEUROCHEMISTRY CLIN: 73 (1980).
- PRUSINER, S.B., ELECTROPHORETIC PROPERTIES OF THE SCRAPIE AGENT IN AGAROSE GELS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 77: 2984 (1980).
- PRUSINER, S.B., SLOW TRANSMISSIBLE D 2: 425 (1979).
- QUALTIERE, L.F., RE-EXAMINATION OF HUMORAL TOLERANCE IN CHICKENS CONGENITALLY INFECTED WITH AN AVIAN-LEUKOSIS VIRUS, JOURNAL OF IMMUNOLOGY 122: 825 (1979). · doi:10.4049/jimmunol.122.3.825
- REYNOLDS, J.A., MEMBRANE RECEPTORS B 11: 33 (1981).
- ROHWER, R.G., SEARCH CAUSE MULTIPL: 333 (1980).
- ROSE, J.A., COMPREHENSIVE VIROLOGY 3: 1 (1974).
- SCHAFFER, F.L., ADV VIRUS RES 6: 159 (1959). · doi:10.1016/s0065-3527(08)60491-1
- SCHUSTER, H, INACTIVATING AND MUTAGENIC ACTION OF HYDROXYLAMINE ON TOBACCO MOSAIC VIRUS RIBONUCLEIC ACID, VIROLOGY 19: 421 (1963). · doi:10.1016/0042-6822(63)90035-7
- 10.1016/0042-6822(73)90224-9 · doi:10.1016/0042-6822(73)90224-9
- SIAKATOS, A.N., DISCOVERY OF A PARTICLE UNIQUE TO BRAIN AND SPLEEN SUBCELLULAR-FRACTIONS FROM SCRAPIE-INFECTED MICE, JOURNAL OF GENERAL VIROLOGY 43: 417 (1979). · doi:10.1099/0022-1317-43-2-417
- SOMERVILLE, R.A., CHANGES IN A PROTEIN-NUCLEIC ACID COMPLEX FROM SYNAPTIC PLASMA-MEMBRANE OF SCRAPIE-INFECTED MOUSE-BRAIN, BIOCHEMICAL SOCIETY TRANSACTIONS 4: 1112 (1976). · doi:10.1042/bst0041112
- 10.1126/science.81.2113.644 · doi:10.1126/science.81.2113.644
- STOCKMAN, S, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 26: 317 (1913). · doi:10.1016/s0368-1742(13)80060-4
- TESSMAN, I, MUTAGENIC TREATMENT OF DOUBLE- AND SINGLE-STRANDED DNA PHAGES T4 AND S13 WITH HYDROXYLAMINE, VIROLOGY 35: 330 (1968). · doi:10.1016/0042-6822(68)90275-4
- VINOGRAD, J, BUOYANT BEHAVIOR OF VIRAL AND BACTERIAL DNA IN ALKALINE CSCL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 49: 12 (1963).
- WAKSMAN, B.H., TOLERANCE, THYMUS, AND SUPPRESSOR T-CELLS, CLINICAL AND EXPERIMENTAL IMMUNOLOGY 28: 363 (1977).
- Parry, H. B., Virus Diseases and the Nervous System: 99 (1969).
- WILSON, D.R., STUDIES IN SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 60: 267 (1950). · doi:10.1016/s0368-1742(50)80025-5
- YANG, V.W., A SMALL NUCLEAR RIBONUCLEOPROTEIN IS REQUIRED FOR SPLICING OF ADENOVIRAL EARLY RNA SEQUENCES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78: 1371 (1981).
- ZLOTNIK, I, ACTA NEUROPATHOLOGICA 1: 61 (1962).
Cited by
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Self-citationAntiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,780
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,277
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
Self-citationThe Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Pathology of Neurodegenerative Diseases
Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655
Self-citationA cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Self-citationPrion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Identification of a Protein That Purifies with the Scrapie Prion
Bolton, D. C., McKinley, M. P., & Prusiner, S. B. (1982) · Science · doi:10.1126/science.6815801 · Cited by 1,280
Self-citation[URE3] as an Altered URE2 Protein: Evidence for a Prion Analog in Saccharomyces cerevisiae
Wickner, R. B. (1994) · Science · doi:10.1126/science.7909170 · Cited by 1,209
Scrapie prion protein contains a phosphatidylinositol glycolipid
STAHL, N. (1987) · Cell · doi:10.1016/0092-8674(87)90150-4 · Cited by 1,112
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,043
Self-citationLegname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021
Self-citationNon–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Amyloid Fibrils of the HET-s(218–289) Prion Form a β Solenoid with a Triangular Hydrophobic Core
Wasmer, C., Lange, A., Van Melckebeke, H., Siemer, A. B., Riek, R., & Meier, B. H. (2008) · Science · doi:10.1126/science.1151839 · Cited by 998
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Goedert, M. (2015) · Science · doi:10.1126/science.1255555 · Cited by 976
A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins
Alberti, S., Halfmann, R., King, O., Kapila, A., & Lindquist, S. (2009) · Cell · doi:10.1016/j.cell.2009.02.044 · Cited by 968
Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., Arnsdorf, M. F., & Lindquist, S. L. (2000) · Science · doi:10.1126/science.289.5483.1317 · Cited by 963
The General Transcription Machinery and General Cofactors
Thomas, M. C., & Chiang, C.-M. (2006) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230600648736 · Cited by 925
Prusiner, S. B., Scott, M. R., DeArmond, S. J., & Cohen, F. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81163-0 · Cited by 923
Self-citationA protease-resistant protein is a structural component of the Scrapie prion
McKinley, M. P., Bolton, D. C., & Prusiner, S. B. (1983) · Cell · doi:10.1016/0092-8674(83)90207-6 · Cited by 917
Self-citationDegradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
Prusiner, S. B., Scott, M., Foster, D., Pan, K.-M., Groth, D., Mirenda, C., Torchia, M., Yang, S.-L., Serban, D., Carlson, G. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90134-z · Cited by 871
Self-citationParkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
Basler, K., Oesch, B., Scott, M., Westaway, D., Wälchli, M., Groth, D. F., McKinley, M. P., Prusiner, S. B., & Weissmann, C. (1986) · Cell · doi:10.1016/0092-8674(86)90662-8 · Cited by 835
Self-citationSpreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00025 · Cited by 774
Therapeutically harnessing extracellular vesicles
Cheng, L., & Hill, A. F. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00410-w · Cited by 737
NMR characterization of the full‐length recombinant murine prion protein, m PrP(23–231)
Riek, R., Hornemann, S., Wider, G., Glockshuber, R., & Wüthrich, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00920-4 · Cited by 722
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715
Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Wälchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. J., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90608-9 · Cited by 697
Self-citationWadsworth, J., Joiner, S., Hill, A., Campbell, T., Desbruslais, M., Luthert, P., & Collinge, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05403-4 · Cited by 693
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., Patel, S., Oehler, A., Lowe, J. K., Kravitz, S. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514475112 · Cited by 689
Self-citationProtein aggregation kinetics, mechanism, and curve-fitting: A review of the literature
Morris, A. M., Watzky, M. A., & Finke, R. G. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.016 · Cited by 680
Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13452 · Cited by 674
Self-citationAcridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Self-citationCell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641
Bessen, R. A., & Marsh, R. F. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.7859-7868.1994 · Cited by 665
Generating a Prion with Bacterially Expressed Recombinant Prion Protein
Wang, F., Wang, X., Yuan, C.-G., & Ma, J. (2010) · Science · doi:10.1126/science.1183748 · Cited by 661
Caughey, B., & Raymond, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55257-1 · Cited by 637
Propagation of Tau aggregates and neurodegeneration
Goedert, M., Eisenberg, D. S., & Crowther, R. A. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031153 · Cited by 632
Formation of native prions from minimal components in vitro
Deleault, N. R., Harris, B. T., Rees, J. R., & Supattapone, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702662104 · Cited by 631
Separation and properties of cellular and scrapie prion proteins.
Meyer, R. K., McKinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A., & Prusiner, S. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2310 · Cited by 623
Self-citationArendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing
Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L., & Prusiner, S. B. (1993) · Biochemistry · doi:10.1021/bi00059a016 · Cited by 583
Self-citationBiology of Amyloid: Structure, Function, and Regulation
Greenwald, J., & Riek, R. (2010) · Structure · doi:10.1016/j.str.2010.08.009 · Cited by 575
Sporadic and familial CJD: classification and characterisation
Gambetti, P., Kong, Q., Zou, W., Parchi, P., & Chen, S. G. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.213 · Cited by 569
Cai, X., Chen, J., Xu, H., Liu, S., Jiang, Q.-X., Halfmann, R., & Chen, Z. J. (2014) · Cell · doi:10.1016/j.cell.2014.01.063 · Cited by 567
Prions Affect the Appearance of Other Prions
Derkatch, I. L., Bradley, M. E., Hong, J. Y., & Liebman, S. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00427-5 · Cited by 559
Prions as adaptive conduits of memory and inheritance
Shorter, J., & Lindquist, S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1616 · Cited by 555
Viles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., & Dyson, H. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2042 · Cited by 552
Self-citationAguzzi, A., & Polymenidou, M. (2004) · Cell · doi:10.1016/s0092-8674(03)01031-6 · Cited by 544
Exosomes: Small vesicles participating in intercellular communication
Ludwig, A.-K., & Giebel, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.005 · Cited by 537
PATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Self-citationShmerling, D., Hegyi, I., Fischer, M., Blättler, T., Brandner, S., Götz, J., Rülicke, T., Flechsig, E., Cozzio, A., von Mering, C., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81572-x · Cited by 530
Variant Creutzfeldt-Jakob disease
Collinge, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05128-4 · Cited by 512
Amyloid fibrils: Abnormal protein assembly
Rambaran, R. N., & Serpell, L. C. (2008) · Prion · doi:10.4161/pri.2.3.7488 · Cited by 511
The activities of amyloids from a structural perspective
Riek, R., & Eisenberg, D. S. (2016) · Nature · doi:10.1038/nature20416 · Cited by 508
RNA molecules stimulate prion protein conversion
Deleault, N. R., Lucassen, R. W., & Supattapone, S. (2003) · Nature · doi:10.1038/nature01979 · Cited by 505
Prions: Protein Aggregation and Infectious Diseases
Aguzzi, A., & Calella, A. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00006.2009 · Cited by 504
Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Guerrero-Munoz, M. J., Kiritoshi, T., Neugebauer, V., Jackson, G. R., & Kayed, R. (2012) · Scientific Reports · doi:10.1038/srep00700 · Cited by 502
Paushkin, S. V., Kushnirov, V. V., Smirnov, V. N., & Ter-Avanesyan, M. D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00675.x · Cited by 501
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain
Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., Bergstrom, S., Robbins, K., Mayer, L., Keith, J. M., et al. (1985) · Nature · doi:10.1038/315331a0 · Cited by 500
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 499
Purification and structural studies of a major scrapie prion protein
Prusiner, S. B., Groth, D. F., Bolton, D. C., Kent, S. B., & Hood, L. E. (1984) · Cell · doi:10.1016/0092-8674(84)90533-6 · Cited by 493
Self-citationTransgene‐induced gene silencing in plants
Vaucheret, H., Béclin, C., Elmayan, T., Feuerbach, F., Godon, C., Morel, J., Mourrain, P., Palauqui, J., & Vernhettes, S. (1998) · The Plant Journal · doi:10.1046/j.1365-313x.1998.00337.x · Cited by 486
Bruce, M., Chree, A., McConnell, I., Foster, J., Pearson, G., & Fraser, H. (1994) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1994.0036 · Cited by 479
Distinct prion proteins in short and long scrapie incubation period mice
Westaway, D., Goodman, P. A., Mirenda, C. A., McKinley, M. P., Carlson, G. A., & Prusiner, S. B. (1987) · Cell · doi:10.1016/0092-8674(87)90134-6 · Cited by 477
Self-citationColby, D. W., & Prusiner, S. B. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006833 · Cited by 472
Self-citationFurther purification and characterization of scrapie prions
Prusiner, S. B., Bolton, D. C., Groth, D. F., Bowman, K. A., Cochran, S. P., & McKinley, M. P. (1982) · Biochemistry · doi:10.1021/bi00269a050 · Cited by 463
Self-citationBiology and Genetics of Prions Causing Neurodegeneration
Prusiner, S. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155524 · Cited by 455
Self-citationThe propagation of prion-like protein inclusions in neurodegenerative diseases
Goedert, M., Clavaguera, F., & Tolnay, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.04.003 · Cited by 454
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431
Bessen, R. A., & Marsh, R. F. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2096-2101.1992 · Cited by 446
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
Behl, C. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00055-0 · Cited by 445
Bellingham, S. A., Coleman, B. M., & Hill, A. F. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks832 · Cited by 440
Extracellular Vesicles and Neurodegenerative Diseases
Hill, A. F. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0147-18.2019 · Cited by 437
Correlation of structural elements and infectivity of the HET-s prion
Ritter, C., Maddelein, M.-L., Siemer, A. B., Lührs, T., Ernst, M., Meier, B. H., Saupe, S. J., & Riek, R. (2005) · Nature · doi:10.1038/nature03793 · Cited by 437
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
Roles of neuropathology-associated reactive astrocytes: a systematic review
Lawrence, J. M., Schardien, K., Wigdahl, B., & Nonnemacher, M. R. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01526-9 · Cited by 433
Packaging of prions into exosomes is associated with a novel pathway of PrP processing
Vella, L., Sharples, R., Lawson, V., Masters, C., Cappai, R., & Hill, A. (2007) · The Journal of Pathology · doi:10.1002/path.2145 · Cited by 425
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein
Gauczynski, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5863 · Cited by 424
Caughey, B., Raymond, G. J., Ernst, D., & Race, R. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6597-6603.1991 · Cited by 420
Andréoletti, O., Berthon, P., Marc, D., Sarradin, P., Grosclaude, J., van Keulen, L., Schelcher, F., Elsen, J.-M., & Lantier, F. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-3115 · Cited by 418
Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 412
A clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 412
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
Congo Red and amyloids: history and relationship
Yakupova, E. I., Bobyleva, L. G., Vikhlyantsev, I. M., & Bobylev, A. G. (2019) · Bioscience Reports · doi:10.1042/bsr20181415 · Cited by 405
The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 401
Linkage of prion protein and scrapie incubation time genes
Carlson, G. A., Kingsbury, D. T., Goodman, P. A., Coleman, S., Marshall, S. T., DeArmond, S., Westaway, D., & Prusiner, S. B. (1986) · Cell · doi:10.1016/0092-8674(86)90875-5 · Cited by 398
Self-citation
Metadata
- Authors
- Prusiner, S. B.
- Venue
- Science
- Published
- 1982-04-09
- Volume
- 216
- Issue
- 4542
- Pages
- 136-144
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2013679718
- Cited by
- 5,118
- References
- 83
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.